•
Sep 6, 2024
Sep 5, 2024
Aug 14, 2024
Aug 13, 2024
Aug 8, 2024
Aug 29, 2024
Aug 26, 2024
Sep 4, 2024
Aug 28, 2024
Aug 9, 2024
Catalent, Inc. [CTLT] has reported fiscal Q3 loss of $227.00 million.
On a per-share basis, the DE based company said its diluted earnings are $1.26.
The Pharmaceutical Preparations firm posted revenue of $1.04 billion in this period.
Also Read: Catalent, Inc. Reports Third Quarter Fiscal 2023 ResultsCatalent, Inc. Announces Third Quarter Fiscal Year 2023 Earnings Conference WebcastCatalent to Hold Business Update Call Related to Delay of Third Quarter 2023 Results and Receives NYSE Notice Regarding Late Form 10-Q FilingCatalent Announces Postponement of Third Quarter 2023 Results and Conference CallCatalent Delays Third Quarter Results and Conference Call and Provides Update on Fiscal 2023 Guidance